APO Research
Talk to an analyst

APO RESEARCH · REPORT

GLP-1 Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global GLP-1 Drug Industry Growth and Trends Forecast to 2032

28 December 2025112 pages

Choose your research edition.

Industry ResearchGLP-1 Drug Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal GLP-1 Drug Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal GLP-1 Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal GLP-1 Drug Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal GLP-1 Drug Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global GLP-1 Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for GLP-1 Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for GLP-1 Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for GLP-1 Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of GLP-1 Drug include AstraZeneca, Boehringer Ingelheim, Eli Lilly, GlaxoSmithKline (GSK), Hanmi Pharmaceutical Co, Novo Nordisk, Pfizer Inc, Sanofi and Teva Pharmaceutical Industries Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global GLP-1 Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The GLP-1 Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global GLP-1 Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to GLP-1 Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global GLP-1 Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

GLP-1 Drug Market by Company

AstraZeneca

Boehringer Ingelheim

Eli Lilly

GlaxoSmithKline (GSK)

Hanmi Pharmaceutical Co

Novo Nordisk

Pfizer Inc

Sanofi

Teva Pharmaceutical Industries Ltd

Gan & Lee Pharmaceuticals

Huadong Medicine

Jiangsu Hansoh Pharmaceutical Group Co., Ltd.

PegBio Co., Ltd

Shanghai Benemae Pharmaceutical Corporation

Tonghua Dongbao

GLP-1 Drug Segment by Type

Short-acting GLP-1 Drug

Long-acting GLP-1 Drug

GLP-1 Drug Segment by Application

Type 2 Diabetes (T2DM)

Alzheimer's Disease (AD)

Non-alcoholic Steatohepatitis (NASH)

Obesity

Cardiovascular and Cerebrovascular Diseases (CVD)

GLP-1 Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GLP-1 Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of GLP-1 Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GLP-1 Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of GLP-1 Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of GLP-1 Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Short-acting GLP-1 Drug Table 2. Major Company of Long-acting GLP-1 Drug Table 3. Global GLP-1 Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global GLP-1 Drug Sales by Type (2021-2026) & (K Units) Table 5. Global GLP-1 Drug Sales Market Share in Volume by Type (2021-2026) Table 6. Global GLP-1 Drug Sales by Type (2021-2026) & (US$ Million) Table 7. Global GLP-1 Drug Sales Market Share in Value by Type (2021-2026) Table 8. Global GLP-1 Drug Price by Type (2021-2026) & (US$/Unit) Table 9. Global GLP-1 Drug Sales by Type (2027-2032) & (K Units) Table 10. Global GLP-1 Drug Sales Market Share in Volume by Type (2027-2032) Table 11. Global GLP-1 Drug Sales by Type (2027-2032) & (US$ Million) Table 12. Global GLP-1 Drug Sales Market Share in Value by Type (2027-2032) Table 13. Global GLP-1 Drug Price by Type (2027-2032) & (US$/Unit) Table 14. North America GLP-1 Drug Sales by Type (2021-2026) & (K Units) Table 15. North America GLP-1 Drug Sales by Type (2021-2026) & (US$ Million) Table 16. Europe GLP-1 Drug Sales by Type (2021-2026) & (K Units) Table 17. Europe GLP-1 Drug Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific GLP-1 Drug Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific GLP-1 Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America GLP-1 Drug Sales by Type (2021-2026) & (K Units) Table 21. Latin America GLP-1 Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa GLP-1 Drug Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa GLP-1 Drug Sales by Type (2021-2026) & (US$ Million) Table 24. GLP-1 Drug Industry Trends Table 25. GLP-1 Drug Industry Drivers Table 26. GLP-1 Drug Industry Opportunities and Challenges Table 27. GLP-1 Drug Industry Restraints Table 28. Global GLP-1 Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global GLP-1 Drug Revenue Market Share by Company (2021-2026) Table 30. Global GLP-1 Drug Sales by Company (2021-2026) & (K Units) Table 31. Global GLP-1 Drug Sales Share by Company (2021-2026) Table 32. Global GLP-1 Drug Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global GLP-1 Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global GLP-1 Drug Major Company Production Sites and Headquarters Table 35. Global GLP-1 Drug Company, Product Type & Application Table 36. Global GLP-1 Drug Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global GLP-1 Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global GLP-1 Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global GLP-1 Drug Sales by Region (2021-2026) & (K Units) Table 41. Global GLP-1 Drug Sales Market Share in Volume by Region (2021-2026) Table 42. Global GLP-1 Drug Sales by Region (2021-2026) & (US$ Million) Table 43. Global GLP-1 Drug Sales Market Share in Value by Region (2021-2026) Table 44. Global GLP-1 Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global GLP-1 Drug Sales by Region (2027-2032) & (K Units) Table 46. Global GLP-1 Drug Sales Market Share in Volume by Region (2027-2032) Table 47. Global GLP-1 Drug Sales by Region (2027-2032) & (US$ Million) Table 48. Global GLP-1 Drug Sales Market Share in Value by Region (2027-2032) Table 49. Global GLP-1 Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global GLP-1 Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global GLP-1 Drug Sales by Application (2021-2026) & (K Units) Table 52. Global GLP-1 Drug Sales Market Share in Volume by Application (2021-2026) Table 53. Global GLP-1 Drug Sales by Application (2021-2026) & (US$ Million) Table 54. Global GLP-1 Drug Sales Market Share in Value by Application (2021-2026) Table 55. Global GLP-1 Drug Price by Application (2021-2026) & (US$/Unit) Table 56. Global GLP-1 Drug Sales by Application (2027-2032) & (K Units) Table 57. Global GLP-1 Drug Sales Market Share in Volume by Application (2027-2032) Table 58. Global GLP-1 Drug Sales by Application (2027-2032) & (US$ Million) Table 59. Global GLP-1 Drug Sales Market Share in Value by Application (2027-2032) Table 60. Global GLP-1 Drug Price by Application (2027-2032) & (US$/Unit) Table 61. North America GLP-1 Drug Sales by Application (2021-2026) & (K Units) Table 62. North America GLP-1 Drug Sales by Application (2021-2026) & (US$ Million) Table 63. Europe GLP-1 Drug Sales by Application (2021-2026) & (K Units) Table 64. Europe GLP-1 Drug Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific GLP-1 Drug Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific GLP-1 Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America GLP-1 Drug Sales by Application (2021-2026) & (K Units) Table 68. Latin America GLP-1 Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa GLP-1 Drug Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa GLP-1 Drug Sales by Application (2021-2026) & (US$ Million) Table 71. AstraZeneca Company Information Table 72. AstraZeneca Business Overview Table 73. AstraZeneca GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. AstraZeneca GLP-1 Drug Product Portfolio Table 75. AstraZeneca Recent Development Table 76. Boehringer Ingelheim Company Information Table 77. Boehringer Ingelheim Business Overview Table 78. Boehringer Ingelheim GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Boehringer Ingelheim GLP-1 Drug Product Portfolio Table 80. Boehringer Ingelheim Recent Development Table 81. Eli Lilly Company Information Table 82. Eli Lilly Business Overview Table 83. Eli Lilly GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Eli Lilly GLP-1 Drug Product Portfolio Table 85. Eli Lilly Recent Development Table 86. GlaxoSmithKline (GSK) Company Information Table 87. GlaxoSmithKline (GSK) Business Overview Table 88. GlaxoSmithKline (GSK) GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. GlaxoSmithKline (GSK) GLP-1 Drug Product Portfolio Table 90. GlaxoSmithKline (GSK) Recent Development Table 91. Hanmi Pharmaceutical Co Company Information Table 92. Hanmi Pharmaceutical Co Business Overview Table 93. Hanmi Pharmaceutical Co GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Hanmi Pharmaceutical Co GLP-1 Drug Product Portfolio Table 95. Hanmi Pharmaceutical Co Recent Development Table 96. Novo Nordisk Company Information Table 97. Novo Nordisk Business Overview Table 98. Novo Nordisk GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Novo Nordisk GLP-1 Drug Product Portfolio Table 100. Novo Nordisk Recent Development Table 101. Pfizer Inc Company Information Table 102. Pfizer Inc Business Overview Table 103. Pfizer Inc GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Pfizer Inc GLP-1 Drug Product Portfolio Table 105. Pfizer Inc Recent Development Table 106. Sanofi Company Information Table 107. Sanofi Business Overview Table 108. Sanofi GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Sanofi GLP-1 Drug Product Portfolio Table 110. Sanofi Recent Development Table 111. Teva Pharmaceutical Industries Ltd Company Information Table 112. Teva Pharmaceutical Industries Ltd Business Overview Table 113. Teva Pharmaceutical Industries Ltd GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Teva Pharmaceutical Industries Ltd GLP-1 Drug Product Portfolio Table 115. Teva Pharmaceutical Industries Ltd Recent Development Table 116. Gan & Lee Pharmaceuticals Company Information Table 117. Gan & Lee Pharmaceuticals Business Overview Table 118. Gan & Lee Pharmaceuticals GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Gan & Lee Pharmaceuticals GLP-1 Drug Product Portfolio Table 120. Gan & Lee Pharmaceuticals Recent Development Table 121. Huadong Medicine Company Information Table 122. Huadong Medicine Business Overview Table 123. Huadong Medicine GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Huadong Medicine GLP-1 Drug Product Portfolio Table 125. Huadong Medicine Recent Development Table 126. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Company Information Table 127. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Business Overview Table 128. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Product Portfolio Table 130. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Recent Development Table 131. PegBio Co., Ltd Company Information Table 132. PegBio Co., Ltd Business Overview Table 133. PegBio Co., Ltd GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. PegBio Co., Ltd GLP-1 Drug Product Portfolio Table 135. PegBio Co., Ltd Recent Development Table 136. Shanghai Benemae Pharmaceutical Corporation Company Information Table 137. Shanghai Benemae Pharmaceutical Corporation Business Overview Table 138. Shanghai Benemae Pharmaceutical Corporation GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Shanghai Benemae Pharmaceutical Corporation GLP-1 Drug Product Portfolio Table 140. Shanghai Benemae Pharmaceutical Corporation Recent Development Table 141. Tonghua Dongbao Company Information Table 142. Tonghua Dongbao Business Overview Table 143. Tonghua Dongbao GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Tonghua Dongbao GLP-1 Drug Product Portfolio Table 145. Tonghua Dongbao Recent Development Table 146. North America GLP-1 Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. North America GLP-1 Drug Sales by Country (2021-2026) & (K Units) Table 148. North America GLP-1 Drug Sales Market Share by Country (2021-2026) Table 149. North America GLP-1 Drug Sales Forecast by Country (2027-2032) & (K Units) Table 150. North America GLP-1 Drug Sales Market Share Forecast by Country (2027-2032) Table 151. North America GLP-1 Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. North America GLP-1 Drug Market Size by Country (2021-2026) & (US$ Million) Table 153. North America GLP-1 Drug Market Share by Country (2021-2026) Table 154. North America GLP-1 Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. North America GLP-1 Drug Market Share Forecast by Country (2027-2032) Table 156. Europe GLP-1 Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Europe GLP-1 Drug Sales by Country (2021-2026) & (K Units) Table 158. Europe GLP-1 Drug Sales Market Share by Country (2021-2026) Table 159. Europe GLP-1 Drug Sales Forecast by Country (2027-2032) & (K Units) Table 160. Europe GLP-1 Drug Sales Market Share Forecast by Country (2027-2032) Table 161. Europe GLP-1 Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Europe GLP-1 Drug Market Size by Country (2021-2026) & (US$ Million) Table 163. Europe GLP-1 Drug Market Share by Country (2021-2026) Table 164. Europe GLP-1 Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Europe GLP-1 Drug Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific GLP-1 Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific GLP-1 Drug Sales by Country (2021-2026) & (K Units) Table 168. Asia-Pacific GLP-1 Drug Sales Market Share by Country (2021-2026) Table 169. Asia-Pacific GLP-1 Drug Sales Forecast by Country (2027-2032) & (K Units) Table 170. Asia-Pacific GLP-1 Drug Sales Market Share Forecast by Country (2027-2032) Table 171. Asia-Pacific GLP-1 Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Asia-Pacific GLP-1 Drug Market Size by Country (2021-2026) & (US$ Million) Table 173. Asia-Pacific GLP-1 Drug Market Share by Country (2021-2026) Table 174. Asia-Pacific GLP-1 Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Asia-Pacific GLP-1 Drug Market Share Forecast by Country (2027-2032) Table 176. Latin America GLP-1 Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 177. Latin America GLP-1 Drug Sales by Country (2021-2026) & (K Units) Table 178. Latin America GLP-1 Drug Sales Market Share by Country (2021-2026) Table 179. Latin America GLP-1 Drug Sales Forecast by Country (2027-2032) & (K Units) Table 180. Latin America GLP-1 Drug Sales Market Share Forecast by Country (2027-2032) Table 181. Latin America GLP-1 Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Latin America GLP-1 Drug Market Size by Country (2021-2026) & (US$ Million) Table 183. Latin America GLP-1 Drug Market Share by Country (2021-2026) Table 184. Latin America GLP-1 Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Latin America GLP-1 Drug Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa GLP-1 Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa GLP-1 Drug Sales by Country (2021-2026) & (K Units) Table 188. Middle East and Africa GLP-1 Drug Sales Market Share by Country (2021-2026) Table 189. Middle East and Africa GLP-1 Drug Sales Forecast by Country (2027-2032) & (K Units) Table 190. Middle East and Africa GLP-1 Drug Sales Market Share Forecast by Country (2027-2032) Table 191. Middle East and Africa GLP-1 Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Middle East and Africa GLP-1 Drug Market Size by Country (2021-2026) & (US$ Million) Table 193. Middle East and Africa GLP-1 Drug Market Share by Country (2021-2026) Table 194. Middle East and Africa GLP-1 Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Middle East and Africa GLP-1 Drug Market Share Forecast by Country (2027-2032) Table 196. Key Raw Materials Table 197. Raw Materials Key Suppliers Table 198. GLP-1 Drug Distributors List Table 199. GLP-1 Drug Customers List Table 200. Research Programs/Design for This Report Table 201. Authors List of This Report Table 202. Secondary Sources Table 203. Primary Sources List of Figures Figure 1. GLP-1 Drug Image Figure 2. Global GLP-1 Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global GLP-1 Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global GLP-1 Drug Sales (2021-2032) & (K Units) Figure 5. Short-acting GLP-1 Drug Image Figure 6. Global Short-acting GLP-1 Drug Sales YoY Growth (2021-2032) & (K Units) Figure 7. Long-acting GLP-1 Drug Image Figure 8. Global Long-acting GLP-1 Drug Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global GLP-1 Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global GLP-1 Drug Market Share by Type 2025 VS 2032 Figure 11. North America GLP-1 Drug Sales Market Share in Volume by Type in 2025 Figure 12. North America GLP-1 Drug Sales Market Share in Value by Type in 2025 Figure 13. Europe GLP-1 Drug Sales Market Share in Volume by Type in 2025 Figure 14. Europe GLP-1 Drug Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific GLP-1 Drug Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific GLP-1 Drug Sales Market Share in Value by Type in 2025 Figure 17. Latin America GLP-1 Drug Sales Market Share in Volume by Type in 2025 Figure 18. Latin America GLP-1 Drug Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa GLP-1 Drug Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa GLP-1 Drug Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 GLP-1 Drug Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Type 2 Diabetes (T2DM) Image Figure 24. Global Type 2 Diabetes (T2DM) Sales YoY Growth (2021-2032) & (K Units) Figure 25. Alzheimer's Disease (AD) Image Figure 26. Global Alzheimer's Disease (AD) Sales YoY Growth (2021-2032) & (K Units) Figure 27. Non-alcoholic Steatohepatitis (NASH) Image Figure 28. Global Non-alcoholic Steatohepatitis (NASH) Sales YoY Growth (2021-2032) & (K Units) Figure 29. Obesity Image Figure 30. Global Obesity Sales YoY Growth (2021-2032) & (K Units) Figure 31. Cardiovascular and Cerebrovascular Diseases (CVD) Image Figure 32. Global Cardiovascular and Cerebrovascular Diseases (CVD) Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global GLP-1 Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global GLP-1 Drug Market Share by Application 2025 VS 2032 Figure 35. North America GLP-1 Drug Sales Market Share in Volume by Application in 2025 Figure 36. North America GLP-1 Drug Sales Market Share in Value by Application in 2025 Figure 37. Europe GLP-1 Drug Sales Market Share in Volume by Application in 2025 Figure 38. Europe GLP-1 Drug Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific GLP-1 Drug Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific GLP-1 Drug Sales Market Share in Value by Application in 2025 Figure 41. Latin America GLP-1 Drug Sales Market Share in Volume by Application in 2025 Figure 42. Latin America GLP-1 Drug Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa GLP-1 Drug Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa GLP-1 Drug Sales Market Share in Value by Application in 2025 Figure 45. North America GLP-1 Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America GLP-1 Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America GLP-1 Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America GLP-1 Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe GLP-1 Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe GLP-1 Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe GLP-1 Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe GLP-1 Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific GLP-1 Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific GLP-1 Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific GLP-1 Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific GLP-1 Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America GLP-1 Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America GLP-1 Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America GLP-1 Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America GLP-1 Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa GLP-1 Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa GLP-1 Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa GLP-1 Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa GLP-1 Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. GLP-1 Drug Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. GLP-1 Drug Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Short-acting GLP-1 Drug
  • Long-acting GLP-1 Drug
Applications
  • Type 2 Diabetes (T2DM)
  • Alzheimer's Disease (AD)
  • Non-alcoholic Steatohepatitis (NASH)
  • Obesity
  • Cardiovascular and Cerebrovascular Diseases (CVD)
Companies covered
  • AstraZeneca
  • Boehringer Ingelheim
  • Eli Lilly
  • GlaxoSmithKline (GSK)
  • Hanmi Pharmaceutical Co
  • Novo Nordisk
  • Pfizer Inc
  • Sanofi
  • Teva Pharmaceutical Industries Ltd
  • Gan & Lee Pharmaceuticals
  • Huadong Medicine
  • Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
  • PegBio Co., Ltd
  • Shanghai Benemae Pharmaceutical Corporation
  • Tonghua Dongbao

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global GLP-1 Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global GLP-1 Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 GLP-1 Drug Market by Type
  6. 1.3.1 Short-acting GLP-1 Drug
  7. 1.3.2 Long-acting GLP-1 Drug
  8. 1.4 Global GLP-1 Drug Market Size by Type
  9. 1.4.1 Global GLP-1 Drug Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global GLP-1 Drug Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global GLP-1 Drug Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America GLP-1 Drug Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe GLP-1 Drug Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific GLP-1 Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America GLP-1 Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa GLP-1 Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 GLP-1 Drug Industry Trends
  2. 2.2 GLP-1 Drug Industry Drivers
  3. 2.3 GLP-1 Drug Industry Opportunities and Challenges
  4. 2.4 GLP-1 Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by GLP-1 Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by GLP-1 Drug Sales (2021-2026)
  3. 3.3 Global Top Players by GLP-1 Drug Price (2021-2026)
  4. 3.4 Global GLP-1 Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global GLP-1 Drug Major Company Production Sites & Headquarters
  6. 3.6 Global GLP-1 Drug Company, Product Type & Application
  7. 3.7 Global GLP-1 Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global GLP-1 Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 GLP-1 Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 GLP-1 Drug Tier 1, Tier 2, and Tier 3
4 GLP-1 Drug Regional Status and Outlook
  1. 4.1 Global GLP-1 Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global GLP-1 Drug Historic Market Size by Region
  3. 4.2.1 Global GLP-1 Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global GLP-1 Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global GLP-1 Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global GLP-1 Drug Forecasted Market Size by Region
  7. 4.3.1 Global GLP-1 Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global GLP-1 Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global GLP-1 Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 GLP-1 Drug by Application
  1. 5.1 GLP-1 Drug Market by Application
  2. 5.1.1 Type 2 Diabetes (T2DM)
  3. 5.1.2 Alzheimer's Disease (AD)
  4. 5.1.3 Non-alcoholic Steatohepatitis (NASH)
  5. 5.1.4 Obesity
  6. 5.1.5 Cardiovascular and Cerebrovascular Diseases (CVD)
  7. 5.2 Global GLP-1 Drug Market Size by Application
  8. 5.2.1 Global GLP-1 Drug Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global GLP-1 Drug Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global GLP-1 Drug Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America GLP-1 Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe GLP-1 Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific GLP-1 Drug Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America GLP-1 Drug Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa GLP-1 Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 AstraZeneca
  2. 6.1.1 AstraZeneca Company Information
  3. 6.1.2 AstraZeneca Business Overview
  4. 6.1.3 AstraZeneca GLP-1 Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 AstraZeneca GLP-1 Drug Product Portfolio
  6. 6.1.5 AstraZeneca Recent Developments
  7. 6.2 Boehringer Ingelheim
  8. 6.2.1 Boehringer Ingelheim Company Information
  9. 6.2.2 Boehringer Ingelheim Business Overview
  10. 6.2.3 Boehringer Ingelheim GLP-1 Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Boehringer Ingelheim GLP-1 Drug Product Portfolio
  12. 6.2.5 Boehringer Ingelheim Recent Developments
  13. 6.3 Eli Lilly
  14. 6.3.1 Eli Lilly Company Information
  15. 6.3.2 Eli Lilly Business Overview
  16. 6.3.3 Eli Lilly GLP-1 Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Eli Lilly GLP-1 Drug Product Portfolio
  18. 6.3.5 Eli Lilly Recent Developments
  19. 6.4 GlaxoSmithKline (GSK)
  20. 6.4.1 GlaxoSmithKline (GSK) Company Information
  21. 6.4.2 GlaxoSmithKline (GSK) Business Overview
  22. 6.4.3 GlaxoSmithKline (GSK) GLP-1 Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 GlaxoSmithKline (GSK) GLP-1 Drug Product Portfolio
  24. 6.4.5 GlaxoSmithKline (GSK) Recent Developments
  25. 6.5 Hanmi Pharmaceutical Co
  26. 6.5.1 Hanmi Pharmaceutical Co Company Information
  27. 6.5.2 Hanmi Pharmaceutical Co Business Overview
  28. 6.5.3 Hanmi Pharmaceutical Co GLP-1 Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Hanmi Pharmaceutical Co GLP-1 Drug Product Portfolio
  30. 6.5.5 Hanmi Pharmaceutical Co Recent Developments
  31. 6.6 Novo Nordisk
  32. 6.6.1 Novo Nordisk Company Information
  33. 6.6.2 Novo Nordisk Business Overview
  34. 6.6.3 Novo Nordisk GLP-1 Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Novo Nordisk GLP-1 Drug Product Portfolio
  36. 6.6.5 Novo Nordisk Recent Developments
  37. 6.7 Pfizer Inc
  38. 6.7.1 Pfizer Inc Company Information
  39. 6.7.2 Pfizer Inc Business Overview
  40. 6.7.3 Pfizer Inc GLP-1 Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Pfizer Inc GLP-1 Drug Product Portfolio
  42. 6.7.5 Pfizer Inc Recent Developments
  43. 6.8 Sanofi
  44. 6.8.1 Sanofi Company Information
  45. 6.8.2 Sanofi Business Overview
  46. 6.8.3 Sanofi GLP-1 Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Sanofi GLP-1 Drug Product Portfolio
  48. 6.8.5 Sanofi Recent Developments
  49. 6.9 Teva Pharmaceutical Industries Ltd
  50. 6.9.1 Teva Pharmaceutical Industries Ltd Company Information
  51. 6.9.2 Teva Pharmaceutical Industries Ltd Business Overview
  52. 6.9.3 Teva Pharmaceutical Industries Ltd GLP-1 Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Teva Pharmaceutical Industries Ltd GLP-1 Drug Product Portfolio
  54. 6.9.5 Teva Pharmaceutical Industries Ltd Recent Developments
  55. 6.10 Gan & Lee Pharmaceuticals
  56. 6.10.1 Gan & Lee Pharmaceuticals Company Information
  57. 6.10.2 Gan & Lee Pharmaceuticals Business Overview
  58. 6.10.3 Gan & Lee Pharmaceuticals GLP-1 Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Gan & Lee Pharmaceuticals GLP-1 Drug Product Portfolio
  60. 6.10.5 Gan & Lee Pharmaceuticals Recent Developments
  61. 6.11 Huadong Medicine
  62. 6.11.1 Huadong Medicine Company Information
  63. 6.11.2 Huadong Medicine Business Overview
  64. 6.11.3 Huadong Medicine GLP-1 Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Huadong Medicine GLP-1 Drug Product Portfolio
  66. 6.11.5 Huadong Medicine Recent Developments
  67. 6.12 Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
  68. 6.12.1 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Company Information
  69. 6.12.2 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Business Overview
  70. 6.12.3 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Product Portfolio
  72. 6.12.5 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Recent Developments
  73. 6.13 PegBio Co., Ltd
  74. 6.13.1 PegBio Co., Ltd Company Information
  75. 6.13.2 PegBio Co., Ltd Business Overview
  76. 6.13.3 PegBio Co., Ltd GLP-1 Drug Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 PegBio Co., Ltd GLP-1 Drug Product Portfolio
  78. 6.13.5 PegBio Co., Ltd Recent Developments
  79. 6.14 Shanghai Benemae Pharmaceutical Corporation
  80. 6.14.1 Shanghai Benemae Pharmaceutical Corporation Company Information
  81. 6.14.2 Shanghai Benemae Pharmaceutical Corporation Business Overview
  82. 6.14.3 Shanghai Benemae Pharmaceutical Corporation GLP-1 Drug Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Shanghai Benemae Pharmaceutical Corporation GLP-1 Drug Product Portfolio
  84. 6.14.5 Shanghai Benemae Pharmaceutical Corporation Recent Developments
  85. 6.15 Tonghua Dongbao
  86. 6.15.1 Tonghua Dongbao Company Information
  87. 6.15.2 Tonghua Dongbao Business Overview
  88. 6.15.3 Tonghua Dongbao GLP-1 Drug Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Tonghua Dongbao GLP-1 Drug Product Portfolio
  90. 6.15.5 Tonghua Dongbao Recent Developments
7 North America by Country
  1. 7.1 North America GLP-1 Drug Sales by Country
  2. 7.1.1 North America GLP-1 Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America GLP-1 Drug Sales by Country (2021-2026)
  4. 7.1.3 North America GLP-1 Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America GLP-1 Drug Market Size by Country
  6. 7.2.1 North America GLP-1 Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America GLP-1 Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America GLP-1 Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe GLP-1 Drug Sales by Country
  2. 8.1.1 Europe GLP-1 Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe GLP-1 Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe GLP-1 Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe GLP-1 Drug Market Size by Country
  6. 8.2.1 Europe GLP-1 Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe GLP-1 Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe GLP-1 Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific GLP-1 Drug Sales by Country
  2. 9.1.1 Asia-Pacific GLP-1 Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific GLP-1 Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific GLP-1 Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific GLP-1 Drug Market Size by Country
  6. 9.2.1 Asia-Pacific GLP-1 Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific GLP-1 Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific GLP-1 Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America GLP-1 Drug Sales by Country
  2. 10.1.1 South America GLP-1 Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America GLP-1 Drug Sales by Country (2021-2026)
  4. 10.1.3 South America GLP-1 Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America GLP-1 Drug Market Size by Country
  6. 10.2.1 South America GLP-1 Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America GLP-1 Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America GLP-1 Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa GLP-1 Drug Sales by Country
  2. 11.1.1 Middle East and Africa GLP-1 Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa GLP-1 Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa GLP-1 Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa GLP-1 Drug Market Size by Country
  6. 11.2.1 Middle East and Africa GLP-1 Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa GLP-1 Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa GLP-1 Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 GLP-1 Drug Value Chain Analysis
  2. 12.1.1 GLP-1 Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 GLP-1 Drug Production Mode & Process
  7. 12.2 GLP-1 Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 GLP-1 Drug Distributors
  10. 12.2.3 GLP-1 Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst